These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 6234571)

  • 1. [Present status of the resistance of enterobacteria to the combination of a sulfonamide and trimethoprim].
    Riou B; Richard C; Rimailho A; Bottineau G; Coquin Y; Auzepy P
    Presse Med; 1984 Jun; 13(26):1637-8. PubMed ID: 6234571
    [No Abstract]   [Full Text] [Related]  

  • 2. Co-trimoxazole resistance in Jamaica.
    Macfarlane DE
    Lancet; 1986 Apr; 1(8486):923. PubMed ID: 2870396
    [No Abstract]   [Full Text] [Related]  

  • 3. Co-trimoxazole susceptibility tests improved with separate trimethoprim and sulfamethoxazole disks.
    Amyes SG
    J Clin Microbiol; 1981 Apr; 13(4):613-7. PubMed ID: 7014612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In-vitro comparative study of Lidaprim and co-trimoxazole.
    Abdel-Messih EF; Suleiman MN; Baron JM
    J Int Med Res; 1984; 12(3):219-20. PubMed ID: 6376211
    [No Abstract]   [Full Text] [Related]  

  • 5. [Sensitivity of enterobacteriaceae to sulfamethoxazole (SMZ), trimethoprim (TMP) and cotrimexazole (SMZ plus TMP)].
    Lynch B; Valenzuela MC; Donoso E; Cofre J; Vilches A; Aguero ME
    Rev Chil Pediatr; 1975; 46(1):17-9. PubMed ID: 1178944
    [No Abstract]   [Full Text] [Related]  

  • 6. [In vitro sensitivity of human pathogens to the drug combination sulfamethoxazole-trimethoprim].
    Lebek G; Wiedmer E
    Schweiz Med Wochenschr; 1971 Sep; 101(38):1385-90. PubMed ID: 4946735
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of changing selection pressures on trimethoprim resistance in Enterobacteriaceae.
    Towner KJ; Slack RC
    Eur J Clin Microbiol; 1986 Oct; 5(5):502-6. PubMed ID: 3490973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bacterial resistance to trimethoprim-sulfamethoxazole.
    N Engl J Med; 1982 Jul; 307(1):60-2. PubMed ID: 7043275
    [No Abstract]   [Full Text] [Related]  

  • 9. [Septrin. Sensitivity of pathogenic bacteria to Septrin].
    Gutkowska J; Zalewski T; Zmudzka B
    Pol Tyg Lek; 1973 Oct; 28(41):1608-10. PubMed ID: 4765468
    [No Abstract]   [Full Text] [Related]  

  • 10. Infection caused by thymidine-requiring, trimethoprim-resistant bacteria.
    King CH; Shlaes DM; Dul MJ
    J Clin Microbiol; 1983 Jul; 18(1):79-83. PubMed ID: 6604070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trimethoprim resistance in gram negative urinary pathogens.
    Platt DJ; Timbury MC
    Br Med J (Clin Res Ed); 1985 Feb; 290(6468):638. PubMed ID: 3918701
    [No Abstract]   [Full Text] [Related]  

  • 12. [Susceptibility of gram negative bacteria to TMP-SMX and ofloxacin].
    Unal S; Aydin M; Akin A
    Mikrobiyol Bul; 1988; 22(4):316-21. PubMed ID: 3266971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trimethoprim resistance and single-agent use.
    Maskell R; Pead L
    Lancet; 1989 Sep; 2(8662):557-8. PubMed ID: 2570249
    [No Abstract]   [Full Text] [Related]  

  • 14. Incidence of trimethoprim-sulfamethoxazole-resistant enterobacteriaceae among transplant recipients.
    Wells CL; Podzorski RP; Peterson PK; Ramsay NK; Simmons RL; Rhame FS
    J Infect Dis; 1984 Nov; 150(5):699-706. PubMed ID: 6387000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emergence of sulfamethoxazole-trimethoprim resistant Shigella flexneri in Northeastern Brazil.
    Tiemens KM; Shipley PL; Correia RA; Shields DS; Guerrant RL
    Arq Gastroenterol; 1985; 22(4):162-5. PubMed ID: 3915680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of co-trimoxazole on faecal enterobacteria: no emergence of resistant strains.
    Moorhouse EC; Farrell W
    J Med Microbiol; 1973 May; 6(2):249-52. PubMed ID: 4575275
    [No Abstract]   [Full Text] [Related]  

  • 17. [The resistance of urinary tract bacteria in hospital environment over a 4-year period. A prospective study with special reference to trimethoprim, sulfonamide and a combination of them].
    Busk HE; Korner B; Hammer R
    Ugeskr Laeger; 1985 Nov; 147(48):3895-7. PubMed ID: 3878615
    [No Abstract]   [Full Text] [Related]  

  • 18. Epidemic Shigella sonnei resistant to co-trimoxazole.
    Pérez Trallero E; López Lopatequi C; Jiménez Alfaro JA; García Arenzana JM
    Lancet; 1981 Oct; 2(8249):751. PubMed ID: 6116883
    [No Abstract]   [Full Text] [Related]  

  • 19. Development of plasmid-mediated resistance in Vibrio cholerae during treatment with trimethoprim-sulfamethoxazole.
    Dupont MJ; Jouvenot M; Couetdic G; Michel-Briand Y
    Antimicrob Agents Chemother; 1985 Feb; 27(2):280-1. PubMed ID: 3885851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High prevalence of non-epidemic Shigella sonnei resistant to co-trimoxazole.
    Palenque E; Otero JR; Noriega AR
    J Antimicrob Chemother; 1983 Feb; 11(2):196-8. PubMed ID: 6339462
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.